[Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].

@article{Brambilla1995ComparativeTO,
  title={[Comparative trial of the clinical efficacy and tolerance of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in superinfections of chronic obstructive bronchopneumopathies in adults in urban practice].},
  author={Christian Brambilla and Daniel Benhamou and J. C. Guerin and E Kelkel and J. F. Muir and Anne Prud'homme and Andr{\'e} Taytard and A Fauche},
  journal={Pathologie-biologie},
  year={1995},
  volume={43 9},
  pages={815-24}
}
In order to compare the clinical efficacy and safety of cefatrizine (Cefaperos) and cefpodoxime proxetil (Orelox) in the treatment of secondarily infected chronic obstructive pulmonary disease (COPD) in adults, a multicentre, randomized, open study was conducted by 60 general practitioners in two parallel groups of patient suffering from COPD complicated by an acute episode of superinfection (Anthoniesen stages 2 and 3). After verification of the eligibility criteria, written consent and… CONTINUE READING